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Abstract
Background: Adult mesenchymal stem cells (MSCs) can be maintained over extended periods of time before activation and
differentiation. Little is known about the programs that sustain the survival of these cells.
Principal Findings: Undifferentiated adult human MSCs (hMSCs) did not undergo apoptosis in response to different cell
death inducers. Conversely, the same inducers can readily induce apoptosis when hMSCs are engaged in the early stages of
differentiation. The survival of undifferentiated cells is linked to the expression of Bcl-Xl and Bcl-2 in completely opposite
ways. Bcl-Xl is expressed at similar levels in undifferentiated and differentiated hMSCs while Bcl-2 is expressed only in
differentiated cells. In undifferentiated hMSCs, the down-regulation of Bcl-Xl is associated with an increased sensitivity to
apoptosis while the ectopic expression of Bcl-2 induced apoptosis. This apoptosis is linked to the presence of cytoplasmic
Nur 77 in undifferentiated hMSCs.
Significance: In hMSCs, the expression of Bcl-2 depends on cellular differentiation and can be either pro- or anti-apoptotic.
Bcl-Xl, on the other hand, exhibits an anti-apoptotic activity under all conditions.
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Introduction
Self-renewal and limited proliferation are the processes that
allow the maintenance of the stem cell pools throughout life [1].
Stem cells must thus maintain their molecular blueprints over long
periods of time and this quality control is achieved, in part,
through the induction of cell death in damaged cells [2].
Mesenchymal stem cells or bone marrow stromal cells (MSCs)
are committed to mesenchymal cell lineages such as bone,
cartilage, tendon, ligament, adipocytes and muscle; and possibly
to other cell types such as neurons [3–5]. MSCs are also essential
for the proliferation and differentiation of hematopoietic cells
within the bone marrow compartment [3–5]. Beyond their
transdifferentiation process, MSCs are also involved in tissue
repair and recently have been considered as an ideal therapeutic
vehicle in many diseases [6–7].
One important feature of MSCs is their capacity to survive
over long periods of time under homologous conditions but to die
rapidly upon their transfer into another individual [3–5]. These
observations suggest that these cells, which are highly prolifer-
ative in vitro, also possess an efficient cell death machinery. There
is little information about the mechanism of survival of most adult
stem/progenitor cells, although this question must be crucial with
regards to their physiological role(s). Apoptosis is a cell death
program that is instrumental in fetal and adult tissue homeostasis.
It has been shown that fetal MSCs exhibit functional apoptotic
pathways [8]. In agreement with the latter hypothesis, genetically
modified rat MSCs containing an anti-apoptotic Bcl-2 gene
exhibited enhanced cell survival upon intracardiac engraftment
[9]. On the other hand, it has been shown that MSCs can survive
pro-apoptotic anti-cancer treatments [10–11], suggesting that
MSCs are highly resistant to radio-or chemo-induced cell death.
In this study, we have addressed the question of the control of
cell death in these cells. We found that undifferentiated hMSCs
were highly resistant to apoptosis while differentiation, even at the
very early stages, was accompanied by an increase in their
sensitivity to apoptosis. This process is differentially controlled by
members of the BCL-2 family of proteins, which are instrumental
in the induction of apoptosis [12] but have been shown to display
distinct roles during hematopoiesis [13].
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Materials and Methods
Materials
Unless stated otherwise, all cell culture material was obtained
from Gibco (Invitrogen, Cergy Pontoise, France) and all chemicals
were from Sigma-Aldrich (St. Louis, MO, USA). The 14 bone
marrow samples used in this study were obtained from healthy
donors operated at the Dept of Orthopedics at ‘‘Centre
Hospitalier Universitaire de Nantes’’. The average age of patients
was 4163 yrs (ranging from 25 to 56 yrs, 6 males and 8 females).
Human fibroblast cultures were obtained from foreskins obtained
from the Dept of Pediatric at ‘‘Hoˆpital Me`re et Enfant de Nantes’’.
Methods
Ethics statements. Patient data were obtained and handled
according to French laws and recommendations of the French
National Commitee of Ethics (Comite´ Consultatif National
d’Ethique pour les Sciences de la Vie et de la Sante´).
Cell Culture. The bone marrow cells were isolated by density
gradient centrifugation (Ficoll). The cells collected at the interface
were cultured in alpha-MEM modified with ribonucleosides and
deoxyribonucleosides supplemented with 20% fetal calf serum,
with 2 mM L-glutamine, 100 U/mL penicillin, 100 mg/mL
streptomycin (complete medium) in an atmosphere of 5% CO2
and 95% humidity at 37uC. MSC cultures were used between
passages 2 and 10. Cultures were kept at about 75% confluence
and passaged every 5–7 days. Mincing the tissue and trypsin
treatment isolated human foreskin fibroblasts. The fibroblasts
recuperated were cultured in RPMI-1640 supplemented with 10%
fetal calf serum, 2 mM L-glutamine, 100 U/mL penicillin,
100 mg/mL streptomycin in an atmosphere of 5% CO2 and
95% humidity and used between passages 2 and 35. The K562
cells were cultured in RPMI supplemented with 10% fetal calf
serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 mg/mL
streptomycin and Glioma primary cultures (GBM) were cultured
in DMEM supplemented with 10% fetal calf serum, 2 mM L-
glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin, both
in an atmosphere of 5% CO2 and 95% humidity at 37uC. Cell
viability was determined by Trypan blue exclusion on a minimum
of 200 cells using a Countess automated cell counter (Invitrogen).
Hypoxic treatment. Cells were cultured in complete
medium in an atmosphere of 3% O2, 5% CO2 and 95%
humidity at 37uC in a hypoxia chamber (Invivo 400, 3M, France).
Differentiation of MSC. Osteogenic MSC differentiation
was induced in vitro by culturing in NH OsteoDiff medium
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) over 21
days. Osteogenic differentiation was detected by the expression of
alkaline phosphatase using the 5-Bromo-4-chloro-3-indolyl
phosphate/Nitro blue tetrazolium (BCIP/NBT) substrate
(Sigmafast B5655) according to the manufacturer’s instructions.
Adipocytes differentiation was induced in vitro by culturing the cells
in NH AdipoDiff Medium (Miltenyi Biotec France) over 21 days.
Adipocyte differentiation was detected by coloration with Oil Red
O, which colors hydrophobic lipids. Neural transdifferentiation
was induced in hMSCs by culturing the cells for 48 h in complete
medium containing 20 ng/ml human recombinant (hr) bFGF
(100-18B, PeproTech, France) and 20 ng/ml hrEGF (100-15,
PeproTech, France). The cells were then cultured in complete
medium containing 10 ng/ml hrBDNF (Sigma, B-3795) to induce
differentiation along the neuronal pathway.
Transfection and viral infection. hMSCs (106) were
nucleofected with 2 mg plasmid: pGFPmax, pRcCMV (pCMV)
empty or containing the Bcl-2 insert (pBcl-2) using the Amaxa
human MSC nucleofector kit (Lonza, Levallois-Perret, France).
After 16 h post-transfection the cells were used in experiments.
MSC were cultured with lentiviral particles (Sigma-Aldrich) at a
multiplicity of infection of 15 in complete medium for 48 h.
Lentiviral particles used for the knock-down of Bcl-Xl were:
TRCN0000033499, TRCN0000033500, TRCN0000033501,
TRCN0000033502, TRCN0000033503 and for Nur 77:
TRCN0000019425, TRCN0000019426, TRCN0000019427,
TRCN0000019428. The initial experiments were done with the
set of viral particles; however, the repeat experiments were done
with those in bold.
FACScan Analysis. The phenotype of MSC was monitored
by flow cytometry. For phenotypic analysis, conjugated antibodies
were used (cf. Table S1). Briefly, 26105 cells were resuspended in
complete medium for 30 min at 4uC. For intracellular staining,
cells were fixed with 4% paraformaldehyde for 10 min and
permeabilized in PBS containing 0,5 % saponin. The cells were
incubated with the primary antibody for 30 min at 4uC in PBS,
0,25% saponin and then, where necessary, the secondary antibody
was added for 30 min at 4uC. Cells were washed twice in PBS
before analyzed on a FACScalibur (BD Biosciences, Le Pont de
Claix, France) using Cell Quest Pro software. The appropriate
isotype controls were included and a minimum of 10 000 events
were acquired for each condition. The debris was excluded from
the analysis according to their FSC/SSC proprieties. BD ApoAlert
APO 2.7-PE (BD Biosciences) was used to determine the
percentage of apoptotic cells according to the manufacturer’s
instructions.
Quantification of caspase activation. Cells were lysed
vol:vol in Nonidet P-40 (NP-40) lysis buffer (142.5 mM KCl,
5 mM MgCl2, 10 mM HEPES [pH 7.2], 1 mM EDTA, 0.25%
NP-40, 0.2 mM PMSF, 0.1% aprotinin, 1 mg/ml pepstatin and
1 mg/ml leupeptin) at 4uC for 30 min. The protein concentrations
were quantified and the caspase activity was quantified using the
fluorogenic substrate Ac-DEVD-AMC as described by the
manufacturer.
Time-lapse analysis. Time-lapse video-microscopy
experiments were performed using a Zeiss Axiovert 200-M
inverted microscope (Carl Zeiss, Le Pecq, France) and the
AxioVision 4.6 program. Dishes were placed inside an Incubator
XL-3, on a heating insert M06 (37uC) topped with a CO2-cover
HM connected to a CO2 controller that maintained the
environmental CO2 concentration at 5% for the duration of
filming. Digital pictures were acquired and saved every 10 min
over 48 h using an AxioCam MR digital camera. The series of
photographs were displayed as continuous time-lapse movies for
analyses. Cell death was quantified at each acquisition and
represented graphically as number of cell death every hour over
the 48 h.
Western blots. Total proteins were extracted in 1% NP-40,
0,5% sodium-deoxycholate, 0,1% SDS in PBS supplemented with
protease inhibitor cocktail from Roche Diagnostics (Mannheim,
Germany). Protein concentration was determined using Bradford
assay (Biorad, Hercules, CA, USA). Protein extracts were
separated on SDS-PAGE, transferred onto PVDF membrane
(Millipore, St. Quentin-Yvelines, France) and revealed with ECL
(Roche Diagnostics). Primary antibodies were used at 1/1000
dilution: mouse monoclonal anti-actin (MAB1501R, Millipore),
rabbit polyclonal anti-Bax (epitope: aa43–61, DakoCytomation,
Trappes, France), mouse monoclonal anti-Bax2D2 (epitope: aa3-
16, Beckman-Coulter, Fullerton, CA, USA), mouse monoclonal
anti-Bax6A7 (epitope: aa12-24, Beckman-Coulter), rabbit
monoclonal anti-Bcl-x (1018-1, Epitomics, France), rabbit
monoclonal anti-Bcl-2 (1017-1, Epitomics, France), rabbit
monoclonal anti-caspase 3 (sc-7272, Santa Cruz Biotech, Ca,
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USA), rabbit polyclonal anti-Nur 77 (sc-5569, Santa Cruz), HRP-
conjugated secondary antibodies were from Biorad. Quantification
was performed with the software ImageJ.
Immunocytochemistry. Cells were grown on gelatin-coated
glass cover-slips. Cells were fixed in 4% paraformaldehyde for
20 min, permeabilized with 0,1% SDS for 10 min, blocked with
3% BSA for 20 min, and then incubated with primary antibodies
for 1 h followed by secondary Alexa antibodies (Molecular Probes-
Invitrogen) for 1 h. Cells were finally mounted with mowiol
polymerizing solution. Primary antibodies were: rabbit polyclonal
anti-caspase 3active (2305-PC-100, Trevigen, Interchim, France),
mouse monoclonal anti-F1-ATPase (Molecular Probes, Invitrogen)
and rabbit polyclonal anti-F1-ATPase a gift from Pr J. Lunardi.
The cells were analyzed under an inverted Leica TCS-SP1
confocal microscope. A 6361.4 NA oil objective and sequential
scanning was used. The 3D reconstitution was done using the
Amira 3D v4.1.1 Imaging program. The quantification of the co-
localization was done using the Metamorph v7.5.6. Program.
Proximity ligation assay (PLA). This assay enables the
detection and quantification of protein interactions using
secondary antibodies labeled with a pair of oligonucleotides that
will generate a signal when the two PLA probes are in close
proximity (Olink Bioscience, Uppsala, Sweden). The signal is
detected as an individual fluorescent dot. Briefly, the cells were
cultured overnight on gelatinized glass coverslips. Cells were fixed
in 4% paraformaldehyde for 15 min, permeabilized with 0,25%
Triton X-100/PBS for 5 min and blocked in 16blocking solution
for 30 min. Cells were incubated with primary antibodies
polyclonal rabbit anti-Nur 77 and monoclonal mouse anti-Bcl-2
diluted in blocking solution overnight at 4uC and then with
secondary antibodies conjugated with oligonucleotides (PLA anti-
mouse MINUS and PLA anti-rabbit PLUS) diluted in blocking
solution for 2 h at 37uC. This was followed by hybridization,
ligation, amplification and detection. The distance between the
two primary antibodies must be less than 40 nm to generate a
signal, which results in a highly specific assay to detect for protein-
protein complexes. The slides were mounted using ProlongH Gold
anti-fade reagent with Dapi (Invitrogen) and then analyzed under
the confocal microscope. A 6361.4 NA oil objective and
sequential scanning with filters 420–480 nm for Dapi and 560–
615 nm for fluorophore Tye-563 were used.
Results
Characterization of hMSCs
MSCs were isolated from human bone marrow samples as
described by Pittenger et al. [14]. After a few days, the cultures
became enriched with fibroblast-like cells that became predomi-
nant after 2 weeks of culture (Figure 1A). The cell population was
characterized by flow cytometric analysis for the expression of
Figure 1. Characterization of in vitro hMSCs. (A) Cell morphology: Photograph of hMSCs cultured in complete medium as described in materials
& methods. Note the fibroblast-like morphology of the cells. (B) Markers (cytometry): Results are represented as FACScan histograms; the gray line
corresponds to the isotype control and the solid black line to the specific antibody tested. Data shown are representative of at least three
independent experiments. (C, D) hMSCs were cultured for 3 weeks in either osteogenic (C) or adipogenic (D) differentiation media. Matrix
mineralization was determined by alkaline phosphatase staining (C) and lipid vacuoles were stained with Oil Red O (D) as described in experimental
procedures. The cultures were visualized under an upright Nikon TMS microscope, magnification620.
doi:10.1371/journal.pone.0019820.g001
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CD105, CD90 and CD44 markers (Figure 1B). There was no
detectable contamination of hematopoietic cells since the cells
were negative for markers of the hematopoietic lineage, including
the lipo-polysaccharide receptor CD14, CD34, and the leukocyte
common antigen CD45 (Figure 1B). The cells were able to
differentiate into several lineages in vitro, including osteoblasts and
adipocytes (Figures 1C and D). Our findings are in agreement
with previous reports and support the conclusion that our
population is enriched with hMSCs [15–16]. Human MSCs cease
to grow after about 20–30 population doublings due to senescence
[17–18]. The most common characteristics of a senescent
phenotype are a gradual decrease in the proliferation potential
and a decrease in differentiation capacity [19–20]. Thus, to avoid
the presence of senescent cells but also that of contaminant or
differentiated cells, we determined that hMSCs should be plated at
an initial concentration of 56104 to 105 and used only between
passages 2 and 10.
Undifferentiated hMSCs are resistant to apoptosis
Contrary to the huge body of data available on the control of
life and death of hematopoietic stem cells, very little data are
available on the mechanisms of survival used by hMSCs [21]. It
has been shown that MSCs were resistant to chemotherapy-
induced apoptosis [10–11], but the actual mechanism(s) of
resistance of these cells to the cell death program were not
determined. Previous data have shown that fetal MSCs are
sensitive to both intrinsic mitochondrial and extrinsic receptor-
mediated apoptotic pathways [8]. We thus examined the response
of the isolated hMSCs to various cell death inducers such as
staurosporine (STS), a broad kinase inhibitor, UV-irradiation and
etoposide (Eto), the latter acting mostly through DNA damage-
induced apoptosis [22]. As shown in Figure 2A, none of these
treatments triggered cell death in hMSCs while K562, an
erythroleukemia cell line was sensitive to these cell death inducers.
It should be added that a dose response effect of etoposide and
staurosporine was done and the effect of the optimal dose was used
to determine the response to cell death over time (data not
shown). We conclude from these results that hMSCs are resistant
to cell death mediated mainly through the mitochondrial apoptotic
pathway.
Next, we investigated the response of these cells to the extrinsic
receptor-mediated apoptotic pathway triggered by soluble Fas
Figure 2. Absence of cell death in hMSCs. (A) Induction of cell death using staurosporine (STS), UV-irradiation and etoposide (Eto) in K562 cells
and hMSCs. The cells were plated at 56104 cells/ml in 24-well plates. 24 h later the different apoptosis inducing agents were added to the culture
medium and the cells were analyzed over 48 h using video-microscopy with an acquisition every 10 min. The number of dead cells was determined
at each time point and rounded up for every hour. The results are presented as the percentage of dead cells in treated cultures versus untreated
cultures. The number of cells analyzed was about 100 per condition. The results are representative of three independent experiments and of 3
different hMSC cultures. (B) Effect of soluble Fas ligand (sFasL) on hMSCs or GBM primary cultures. Quantification of the viability of hMSCs cultured in
the absence or in the presence of increasing concentrations (50, 100, 150, 200 and 250 ng/ml) sFasL and GBM cells cultured in the presence of 50 ng/ml
sFasL was determined by time-lapsemicroscopy over 24 h using 10 min intervals. Cell viability was determined at every acquisition as described in (A.C)
Human MSCs or fibroblasts (hfib) were cultured in the absence or in the presence of etoposide (Eto) at the indicated concentrations over 24 h. The cells
were then lysed and the caspase activity determined in 20 mg cell extract using Ac-DEVD-AMC as a substrate. The results are expressed as arbitrary units
of caspase activity per mg protein. (D) Effect of hypoxia on hMSCs survival. Human MSCs were cultured for 48 h under normoxia (20% O2) or hypoxia
using a hypoxia work-station at 3% O2, 5% CO2 in 95% humidified air. Note that experiments shown are representative of hMSCs obtained from at least
five different donors.
doi:10.1371/journal.pone.0019820.g002
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ligand (sFasL). Time-lapse experiments over 24 h showed less than
10% cell death to concentrations of up to 200 ng/ml sFasL
(Figure 2B). Thus, even at very high concentrations of sFasL,
hMSCs did not undergo apoptosis while at a much lower
concentration (i.e. 50 ng/ml) sFasL induced apoptosis in human
Glioma (GBM) primary cultures (Figure 2B), as previously
described [23]. Next, using caspase activity, a landmark of
apoptosis, we compare the sensitivity toward etoposide-induced
apoptosis in hMSCs to that of primary cultures of human foreskin
fibroblasts (see experimental procedures). As shown in Figure 2C,
hMSCs were resistant to caspase activation by etoposide while
human fibroblasts exhibited maximum caspase activation at the
lowest concentration. As hypoxia and serum-deprivation induced
apoptosis in rat MSCs [24], we examined the effect of hypoxia on
the survival of hMSCs. As shown in Figure 2D, hypoxia did not
induce apoptosis in these cells but on the contrary, it triggered
proliferation as previously described [25].
Lack of cytochrome c release accounts for resistance to
apoptosis in undifferentiated hMSCs
The change in the conformation of Bax, mitochondrial
integration and the subsequent release of cytochrome c (cyt c)
are landmarks of apoptosis [12]. As shown in Figure 3A, an
etoposide-treatment, even at a low concentration (i.e. 50 mg/ml)
triggered an apoptotic change in conformation in Bax in hMSCs
as illustrated by the binding to Bax by the anti-conformational
monoclonal antibody 6A7 [12]. The release of cyt c from
mitochondria is a major step in the execution of apoptosis that
occurs downstream of Bax activation and mitochondrial associ-
ation [12]. Using laser confocal microscopy as previously
described [23], we analyzed the subcellular localization of cyt c
in control and etoposide-treated hMSCs As illustrated in
Figure 3B, no change in the localization of cyt c was observed
in etoposide-treated cells, which remained mitochondrial as
observed in control untreated cells. These results suggest that the
blockade of apoptosis in undifferentiated hMSCs occurred at the
mitochondrial level after Bax activation but before cyt c release.
To analyze, the impact of etoposide treatment on hMSCs growth
and differentiation, osteogenic differentiation was induced in
control and etoposide-treated MSC. As shown in Figure 3C, in
the absence of osteogenic differentiation, control and etoposide-
treated MSC proliferated at the same rate for several days (i.e. up
to 6 days in vitro). However, when differentiation was induced
after etoposide treatment, hMSCs stopped proliferating and died
after 2 days (Figure 3D). This result suggests that although
undifferentiated hMSCs can sustain heavy DNA damage without
the induction of apoptosis these cells cannot differentiate into
mature cells.
Figure 3. Absence of release of cyt c from mitochondria despite the activation of Bax in hMSCs. (A, B) Laser confocal analyses of hMSCs
after etoposide treatment. Cells were cultured in the absence (untreated) or in the presence of 50 mg/ml Etoposide (Eto) for 24 h then labeled with
polyclonal anti-F1-ATPase (mitochondria: green) and either (A) monoclonal anti-Bax
2D2 (2D2: recognizes all forms of Bax: red) and/or anti-Bax6A7 (6A7:
recognizes only the activated form of Bax: red) or (B) monoclonal anti-cyt c (red). Laser confocal analyses were done as described in the material and
methods section. (C, D) Human MSCs were plated into 6-well plates and 24 h later cultured in the absence or presence of 50 mg/ml etoposide (Eto).
24 h later the cells were either cultured in the presence of complete media (C) or in osteogenic differentiation media (D). At the different times
indicated the cells were trypsinized and the number of viable cells determined by trypan blue exclusion.
doi:10.1371/journal.pone.0019820.g003
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The capacity of hMSCs to undergo apoptosis is
associated with differentiation
The latter results suggested that the differentiation process was
accompanied by a change in the sensitivity toward apoptosis. To
address this point, hMSCs were cultured in osteogenic differen-
tiation media for 1 to 3 weeks then treated or not with etoposide.
Cell death was quantified by Trypan blue exclusion 24 h after the
treatment. We found that the initiation of differentiation sensitized
these cells to cell death. Furthermore, as early as one week after
the induction of differentiation, etoposide was able to induce an
effective cell death (Figure 4A). Apoptosis was identified by the
measure of caspase activity (Figure 4B) and analysis with APO
2.7, which both are specific of apoptotic cells [26] (Figure S1).
We next investigated the sensitivity of hMSCs toward cell death
upon the induction of differentiation along the adipogenic or
neuronal pathways. Cells were differentiated then subjected to an
etoposide treatment. Figure 4C illustrates cells engaged in
adipogenic differentiation treated or not with etoposide. In
agreement with our previous observations, only cells engaged along
the adipogenic differentiation pathway were as sensitive to cell death
as human fibroblasts (Figure 4D). Similarly, hMSCs cultured in
the presence of bFGF/EGF and then BDNF to induce neural
differentiation were responsive to etoposide at a concentration,
which did not affect the cells treated only with bFGF/EGF
(Figure 4E). Note that the treatment with etoposide was done in
the absence of BDNF since BDNF is a survival factor and prevents
cell death when present in the medium (data not shown). The
decrease in cell viability was due to an increase in apoptosis as
observed by the induction of caspase activity under these conditions
(Figure 4E). Consistent with these results, we found that Bax was
translocated to the mitochondria and cyt c was released from the
mitochondria in etoposide-treated differentiated cells (Figure S2).
Differential expression of Bcl-2 and Bcl-Xl between
undifferentiated and differentiated hMSCs
The fact that caspase activity could not be detected in
undifferentiated hMSCs upon etoposide, UV or STS treatments
whereas Bax was ‘‘activated’’ in both undifferentiated and
Figure 4. Sensitivity to cell death was acquired after induction of differentiation. (A) Human MSCs were cultured in complete or
osteogenic differentiation medium for 0 to 3 weeks; in the absence or in the presence of 50 mg/ml etoposide (Eto). The number of viable cells was
quantified by Trypan blue exclusion counting a minimum of 200 cells per condition. The data presented represent three independent experiments.
(B) The cells treated as in (A) were collected and 10 mg whole cell lysates were assayed for caspase activity using Ac-DEVD-AMC as a substrate. The
results are expressed as arbitrary units of caspase activity per mg protein. (C) Induction of apoptosis in hMSCs and adipocytes. Pictomicrographs of
adipogenic differentiated hMSCs and hMSCs cultured in the absence or in the presence of 50 mg/ml etoposide (Eto) for 18 h. Images are
representative of 4 independent experiments. (D) The number of cell death in hMSCs, preadipocyte (preadipo) or human fibroblast (hfib) cultures
treated or not with 50 mg/ml etoposide (Eto) for 24 h was determined by Trypan blue exclusion (Countess), counting about 200 cells under each
condition. The data are representative of 3 independent experiments. (E) Human MSCs induced to differentiate along the neuronal pathway (+10 mg/ml
BDNF) or not (without BDNF) were cultured in the presence of 50 mg/ml etoposide (Eto) for 24 h before being assayed for caspase activity using Ac-
DEVD-AMC as a substrate. The results are expressed as arbitrary units of caspase activity per mg protein.
doi:10.1371/journal.pone.0019820.g004
Cell Death and Differentiation of MSCs
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19820
differentiated cells suggests that the mitochondrial apoptotic
pathway was impaired in undifferentiated cells at the mitochon-
drial level. Thus, we analyzed the expression of key proteins of the
apoptotic program in these cells. As shown in Figure 5A,
immunoblots revealed that hMSCs expressed key components of
apoptosis belonging to the BCL-2 family such as the anti-apoptotic
protein Bcl-Xl and the pro-apoptotic protein Bax. Mcl-1 and Bak
were also found in both undifferentiated and differentiated cells
(data not shown). However, undifferentiated hMSCs lack the
expression of Bcl-2. On the other hand, hMSCs also expressed
proteins essential for the execution phase of apoptosis such as
caspase 3 (Figure 5A) and caspase 7, 8 and 9 (data not shown).
Quite remarkably, Bcl-2 was expressed in differentiated cells
although to a lesser degree in osteoblasts than in adipocytes
(Figure 5A). Indeed, it has been reported that primitive human
hematopoietic precursors (i.e. CD34+/lin2) express Bcl-Xl but not
Bcl-2 [27] and that this differential expression influence their
lineage choice [13].
We addressed the question of the involvement of Bcl-Xl and
Bcl-2 in the survival and/or differentiation of hMSCs. First we
down-regulated the expression of Bcl-Xl by shRNA (Figure S3
illustrates the efficiency of the shRNA Bcl-Xl). The knock-down of
Bcl-Xl in hMSCs made these cells susceptible to low concentra-
tions of etoposide (i.e. 50 mg/ml) that was not able to trigger
apoptosis in hMSCs infected with a scr-shRNA (Figure 5B). This
result suggests that Bcl-Xl plays an essential role in protecting
hMSCs against apoptosis. On the other hand, the over-expression
of Bcl-2 (Figure S4) induced a massive cell death in undifferen-
tiated hMSCs and this without the addition of apoptotic inducers
(Figure 5C). To underline this observation, hMSCs transfected
with Bcl-2, treated or not with etoposide, exhibited caspase 3
activity while no activity was detected in mock-transfected cells
treated or not with etoposide (Figure 5D).
Bcl-2 induces apoptosis in undifferentiated hMSCs
though its interaction with Nur 77
Recently, Bcl-2 has been shown to be transformed into a pro-
apoptotic protein upon its binding to Nur 77 (also known as TR3
or NGFI-B) through the Bcl-2 loop region [28]. Nur 77 is present
in hMSCs and there is no increase in its expression during
Figure 5. Expression of key components of the apoptotic machinery in hMSCs. (A) Western blot analyses of some of the main components
of the apoptotic machinery. Total protein extracts were performed and 50 mg protein was analyzed on a 12% SDS-PAGE. Immunodetections were
performed with the antibodies cited in the material and methods section. (B) The sensitivity of the hMSCs-shBcl-Xl-501 and hMSCs-shscr to apoptosis
was determined by culturing the cells in the absence or in the presence of 50 mg/ml etoposide (Eto). The cells were analyzed over 48 h using video-
microscopy with an acquisition every 10 min. The number of dead cells was determined at each time point and rounded up for every hour. The
results are presented as the percentage of dead cells in treated cultures versus untreated cultures. The number of cells analyzed was about 100 per
condition. The results are representative of three independent experiments. (C) Cells were nucleofected with either pCMV or pBcl-2 and 24 h later cell
viability was determined by Trypan blue exclusion. (D) Twenty-four hours after the transfection of hMSCs with pCMV (a, b) or pBcl-2 (c, d); these cells
were cultured in the absence (a, c) or presence (b, d) of 50 mg/ml etoposide (Eto) then analyzed for the expression of active caspase 3 (red) by
confocal microscopy. The data presented are representative of 2 independent experiments.
doi:10.1371/journal.pone.0019820.g005
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osteogenic differentiation (Figure 6A). The expression of Bcl-2 in
undifferentiated hMSCs but not that of a mutant lacking the
binding domain with Nur 77 (i.e. Bcl-2 loop region) induced
apoptosis in these cells (Figure 6B). Data from the proximity
ligation assay (PLA) on hMSCs transfected with either pCMV or
pBcl-2 suggested that Bcl-2 and Nur 77 were in very close
proximity to each other in cells transfected by pBcl-2 as visualized
by the number of fluorescent dots present in these cell
(Figure 6C). Nur 77 is present in both the cytoplasmic and
nuclear compartments in undifferentiated hMSCs but is mostly
mitochondrial in hMSCs (Figure S5A). In Bcl-2 transfected
hMSCs, there was a 50% increase in the amount of Nur 77
inserted into the mitochondria as compared to pCMV-transfected
cells (Figure S5B). A shRNA down-regulation of Nur 77 was
performed in undifferentiated hMSCs (Figure S6). The knock-
down of Nur 77 by ShRNA (ShNur 77-25) decreased significantly
the Bcl-2-induced cell death in undifferentiated hMSCs as
compared to cells transfected with pCMV (Figure 6D). Note
that a scrambled ShRNA did not affect Bcl-2 induced cell death
(Figure 6D). Similar results were obtained with a ShNur 77 (i.e.
ShNur 77-26) that caused no alteration in Nur 77 expression
(data not shown). Taken together, our results suggest that
apoptosis induced by ectopic Bcl-2 in undifferentiated hMSCs is
induced by its interaction with Nur 77.
Discussion
In this study, we have analyzed the relationship between
sensitivity to cell death and differentiation of hMSCs. We have
found that undifferentiated hMSC were highly resistant to
apoptosis until they engaged along a differentiation pathway.
The hMSCs used in this study were isolated from middle-aged
donors; were short-term cultures and used for a limited number of
passages to avoid the interference with senescence (Figure 1). In
this study, we show that hMSCs are resistant to potent apoptosis
inducers at concentrations that otherwise kill cancer cells such as
the K562 cells or human GBM cells as well as primary cultures of
human fibroblasts (Figure 2). The nature of this intrinsic
Figure 6. Interaction between Bcl-2 and Nur 77. (A) Western blot analyses of Nur 77 expression in hMSCs, hMSCs transfected with pBcl-2 and
osteoblasts. This is a representative immunoblot of 2 different experiments. (B) Cells were transfected with plasmids: pCMV, pCMV containing Bcl-2
(pBcl-2) or Bcl-2 deleted in the amino acids 30–85 (pBcl-2Dloop). 16 h post-transfection the cells were plated in 6-well plated and video-filmed over
48 h with acquisition every 10 min. The number of dead cells was determined at each time point and rounded up for every hour. The results are
presented as the percentage of dead cells in treated cultures versus untreated cultures. The number of cells analyzed was minimum 100 per
condition. The results are representative of 3 independent experiments. (C) A PLA between Bcl-2 and Nur 77 was performed on hMSCs transfected
with pCMV or pBcl-2 as described in the materials and methods section. Fluorescence was detected using the fluorophore Tye-563 that excites at
557 nm and emits at 563 nm. The nuclei were stained with Dapi present in the mounting solution (ProlongH Gold anti-fade). Spots indicated
interaction between Nur77 and Bcl-2. These experiments were repeated 3 times, each performed in duplicate. (D) Human MSCs infected with either
shNur77 or shscr were then transfected with pCMV or pBcl-2 and then treated with 50 mg/ml etoposide. Note that for all experiments only Nur77-25
was used. Cell viability was determined by Trypan blue exclusion, 24 h after treatments. The results are representative of 3 different experiments
done in triplicate.
doi:10.1371/journal.pone.0019820.g006
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resistance to apoptosis implies the inhibition of the mitochondrial
intrinsic pathway as demonstrated by the lack of cyt c release upon
the induction of apoptosis in hMSCs (Figure 3). Human MSCs
that have undergone DNA damage during etoposide treatment,
survive and proliferate but die upon differentiation (Figure 3).
However, it should be noted that this treatment might not reflect
the type of DNA damage that could occur under normal
physiological conditions. However, one could postulate that these
features are involved in the elimination of damaged hMSCs. Of
note, upon addition of differentiating factors, hMSCs shift their
sensitivity toward apoptosis inducers (Figure 4). This feature is
not restricted to osteogenic lineage as it can be also observed
during neural and adipocytic differentiation as well (Figure 4).
One important finding in this work is the differential expression
of Bcl-2 between differentiated and undifferentiated hMSCs
(Figure 5). The control of Bcl-2 versus cell differentiation has
been shown in several cell types, including hematopoietic, neural
and epithelial cells [13]. Low levels of Bcl-2 are found in immature
cells and high levels in mature cells in the lymphoid compartment
[29]. Similarly, Bcl-2 expression is up-regulated during the
differentiation of hematopoietic progenitors. Our results strength-
en the hypothesis of a link between low Bcl-2 levels and
‘‘stemness’’ outside the hematopoietic compartment. In hMSCs
this effect appears to be different from its anti-apoptotic role,
which is apparently carried out by Bcl-Xl (Figure 5). The latter
feature is consistent with previous studies that show that Bcl-Xl
functions as a prime regulator of the viability of immature cells
during the development of the nervous and hematopoietic system
[30]. However, in this study we have analyzed the behavior of
isolated hMSCs, a condition that does not necessarily mirror a
physiological situation.
On the other hand, Bcl-2 induces cell death when expressed in
undifferentiated hMSCs though its interaction with Nur 77
(Figure 6). Nur 77 is an orphan member of the nuclear receptor
subfamily 4 that is expressed in many cell types where it plays
several key roles including induction of apoptosis and control of
differentiation. Inhibition of differentiation by Nur 77 through its
transcriptional targets has been documented in adipocytes [31].
On the other hand, it has been shown to induce cell cycle arrest
and differentiation in dopaminergic cells [32]. During TCR-
mediated clonal deletion, Nur 77 appears to be instrumental
through its capacity to induce apoptosis. It is thought that the
translocation of Nur 77 to the cytoplasm promotes cell death,
while its retention in the nucleus promotes survival and
proliferation through transcriptional activity but also via protein-
protein interactions. Two of Nur 77 primary interactive targets are
Bcl-2 and Bcl-B, the binding to which induces a drastic change,
switching their function from anti-apoptotic to pro-apoptotic [28].
However, Nur 77 is not capable of interacting with either Bcl-Xl
or Mcl-1 [33]. The interaction between Nur 77 and Bcl-2 is
instrumental in the induction of apoptosis during negative
selection of autoreactive thymocytes [34]. Here, we show a
parallel mechanism in hMSCs, demonstrating that Bcl-2 is down-
regulated in undifferentiated hMSCs and this down-regulation
preserves these cells from cell death via apoptosis. These results
suggest that a complex cross-regulation between Bcl-2 and Nur 77
controls the survival and the differentiation of hMSCs through a
mechanism similar to that observed during the negative selection
in the immune system [35].
A better understanding of the different mechanisms that
regulate apoptosis in hMSCs could provide important clues on
the relationship between the cell death program and the
differentiation programs in adult stem cells. This could have
important consequences on both cancer and regenerative
medicine.
Supporting Information
Figure S1 Human MSCs were cultured in complete or
osteogenic differentiation medium for 0, 1 or 3 weeks
and in the absence or presence of 50 mg/ml etoposide
(Eto). The cells were trypsinized and the number of apoptotic
cells was labelled with APO 2.7-PE and then quantified by
cytometry. The results are representative of three independent
experiments.
(TIF)
Figure S2 Western blot analyses of Bax and cyt c in
cytoplasmic and mitochondrial fractions from hMSCs
treated or not with 50 mg/ml etoposide.
(TIF)
Figure S3 Western blot analyses of hMSCs infected with
sh-scr and shBcl-Xl-501 showing the Knock-down of Bcl-
Xl.
(TIF)
Figure S4 Western blot analyses of hMSCs transfected
with pCMV and pBcl-2 showing the expression of Bcl-2.
(TIF)
Figure S5 (A) The localization of Nur 77 in hMSCs nucleofected
with pBcl-2 or pCMV was determined by confocal microscopy.
These are representative pictures of 3 different experiments. (B)
Calculation of the percentage of co-localization of Nur 77 (green)
with F1-ATPase (mitochondria: red) in hMSCs transfected with
either pCMV or pBcl-2 using Metamorph 7.5.6. The algorithm
«XOR» was applied to Nur 77 and the «AND» algorithm was
used to threshold the non-colocalized Nur 77. The results are the
mean of 10 views from 3 different experiments.
(TIF)
Figure S6 Western blot analyses of hMSCs infected with
sh-scr or shNur 77 showing the different levels of knock-
down of Nur 77 using the different shNur 77 viral
particles. Note for the experiments Nur 77-25 was used.
(TIF)
Table S1 List of antibodies used to phenotype the
hMSCs by FACS analyses.
(TIF)
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